RANITIDINE tablet, film coated САЩ - английски - NLM (National Library of Medicine)

ranitidine tablet, film coated

nucarepharmaceuticals, inc. - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine 150 mg - ranitidine tablets usp are indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. no placebo-controlled comparative studies have been carried out for periods of longer than 1 year. - the treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome and systemic mastocytosis). - short-term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. - maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. placebo-controlled studies have been carried out

CEPHALEXIN powder, for suspension САЩ - английски - NLM (National Library of Medicine)

cephalexin powder, for suspension

nucarepharmaceuticals, inc. - cephalexin (unii: obn7uds42y) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin anhydrous 125 mg in 5 ml - cephalexin is indicated for the treatment of respiratory tract infections caused by susceptible isolates of streptococcus pneumoniae and streptococcus pyogenes. cephalexin is indicated for the treatment of otitis media caused by susceptible isolates of streptococcus pneumoniae , haemophilus influenzae , staphylococcus aureus , streptococcus pyogenes , and moraxella catarrhalis. cephalexin is indicated for the treatment of skin and skin structure infections caused by susceptible isolates of the following gram-positive bacteria: staphylococcus aureus and streptococcus pyogenes . cephalexin is indicated for the treatment of bone infections caused by susceptible isolates of staphylococcus aureus and proteus mirabilis. cephalexin is indicated for the treatment of genitourinary tract infections, including acute prostatitis, caused by susceptible isol

LISINOPRIL AND HYDROCHLOROTHIAZIDE tablet САЩ - английски - NLM (National Library of Medicine)

lisinopril and hydrochlorothiazide tablet

nucarepharmaceuticals, inc. - lisinopril (unii: e7199s1ywr) (lisinopril anhydrous - unii:7q3p4bs2fd), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - lisinopril 10 mg - lisinopril and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including lisinopril and hydrochlorothiazide. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a vari

ISOSORBIDE MONONITRATE tablet, extended release САЩ - английски - NLM (National Library of Medicine)

isosorbide mononitrate tablet, extended release

nucarepharmaceuticals, inc. - isosorbide mononitrate (unii: lx1oh63030) (isosorbide mononitrate - unii:lx1oh63030) - isosorbide mononitrate extended-release tablets are indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. isosorbide mononitrate extended-release tablets are contraindicated in patients who have shown hypersensitivity or idiosyncratic reactions to other nitrates or nitrites.

Folic Acid 5mg Tablets Великобритания - английски - myHealthbox

folic acid 5mg tablets

crescent pharma ltd - folic acid - tablets - 5mg - folic acid and derivatives - folic acid is necessary for the normal production and maturation of blood cells, and is used in the treatment of nutritional megaloblastic anaemias eg. following gastrectomy and the megaloblastic anaemia of pregnancy. it may also be used prophylactically in chronic haemolytic states or in renal dialysis.

Ascorbic Acid 50mg Tablets Великобритания - английски - myHealthbox

ascorbic acid 50mg tablets

crescent pharma ltd - ascorbic acid - tablets - 50mg - ascorbic acid (vit c), plain - for the treatment of scurvy. prophylactically in cases where deficiency might be expected to occur.

Ascorbic Acid 100mg Tablets. Великобритания - английски - myHealthbox

ascorbic acid 100mg tablets.

crescent pharma limited - ascorbic acid - tablets - 100mg - ascorbic acid (vit c), plain - for the treatment of scurvy. prophylactically in cases where deficiency might be expected to occur

Ascorbic Acid 200mg Tablets. Великобритания - английски - myHealthbox

ascorbic acid 200mg tablets.

crescent pharma limited - ascorbic acid - tablets - 200mg - ascorbic acid (vit c), plain - for use in vitamin c deficiency including the treatment and prevention of scurvy

Ascorbic Acid 500mg Tablets. Великобритания - английски - myHealthbox

ascorbic acid 500mg tablets.

crescent pharma limited - ascorbic acid - tablets - 500mg - ascorbic acid (vit c), plain - for use in treating vitamin c deficiency including the treatment and prevention of scurvy.